oxybutynin has been researched along with Joint Pain in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adult patients with pain from osteoarthritis receiving a stable dosage of HCD/APAP (i." | 6.77 | A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain. ( Landau, CJ; McCarberg, BH; Munera, C; Ripa, SR; Wen, W, 2012) |
| "Worldwide, knee osteoarthritis is one of the leading causes of disability, particularly in the elderly." | 2.78 | Golden plaster for pain therapy in patients with knee osteoarthritis: study protocol for a multicenter randomized, double-blind, placebo-controlled trial. ( Ji, WB; Jiang, H; Li, XF; Liu, JT; Tang, DZ; Tao, S; Wang, YJ; Zhang, ZG, 2013) |
| "Adult patients with pain from osteoarthritis receiving a stable dosage of HCD/APAP (i." | 2.77 | A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain. ( Landau, CJ; McCarberg, BH; Munera, C; Ripa, SR; Wen, W, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, JT | 1 |
| Tang, DZ | 1 |
| Li, XF | 1 |
| Zhang, ZG | 1 |
| Ji, WB | 1 |
| Tao, S | 1 |
| Wang, YJ | 1 |
| Jiang, H | 1 |
| Ozden, R | 1 |
| Uruç, V | 1 |
| Doğramaci, Y | 1 |
| Kalaci, A | 1 |
| Yengil, E | 1 |
| Ripa, SR | 1 |
| McCarberg, BH | 1 |
| Munera, C | 1 |
| Wen, W | 1 |
| Landau, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-Blind Study Evaluating the Dose Conversion From Vicodin® to Buprenorphine Transdermal System (BTDS) in Subjects With Osteoarthritis (OA) Pain[NCT00312572] | Phase 3 | 204 participants (Actual) | Interventional | 2003-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The indicator variable was 1 = completion, and 0 = noncompletion. For the primary efficacy analysis, the percentage of subjects who completed the double-blind phase was computed with its 95% confidence interval (CI) for each treatment regimen (starting dose of BTDS 10 or BTDS 20) across and within baseline Vicodin® stratum (15 to 22.5mg/day vs >22.5 to 30 mg/day as determined by the daily average hydrocodone dose during the run-in period). (NCT00312572)
Timeframe: 14 days
| Intervention | Percentage of Participants (Number) | ||
|---|---|---|---|
| 15 - 22.5 mg HCD (Stratum 1) | more than 22.5 - 30 mg HCD (Stratum 2) | Overall | |
| Combined Total | 85 | 82 | 84 |
| Double-blind BTDS 10/20 | 88 | 85 | 87 |
| Double-blind BTDS 20 | 83 | 79 | 82 |
3 trials available for oxybutynin and Joint Pain
| Article | Year |
|---|---|
Golden plaster for pain therapy in patients with knee osteoarthritis: study protocol for a multicenter randomized, double-blind, placebo-controlled trial.
Topics: Administration, Cutaneous; Aged; Analgesics; Arthralgia; China; Clinical Protocols; Double-Blind Met | 2013 |
Management of tennis elbow with topical glyceryl trinitrate.
Topics: Administration, Topical; Adult; Arthralgia; Female; Hand Strength; Humans; Male; Nitroglycerin; Pain | 2014 |
A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Aged; Analgesics, Opioid; Anti-Infla | 2012 |